ID   KUMA-3
AC   CVCL_SA77
SY   Kuma-3
DR   cancercelllines; CVCL_SA77
DR   IARC_TP53; 28405
DR   Wikidata; Q54900714
RX   PubMed=10741724;
CC   Population: Japanese.
CC   HLA typing: A*24:02,11:01 (PubMed=10741724).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=10741724).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
RX   PubMed=10741724;
RA   Eura M., Chikamatsu K., Katsura F., Obata A., Sobao Y., Takiguchi M.,
RA   Song Y.-S., Appella E., Whiteside T.L., DeLeo A.B.;
RT   "A wild-type sequence p53 peptide presented by HLA-A24 induces
RT   cytotoxic T lymphocytes that recognize squamous cell carcinomas of the
RT   head and neck.";
RL   Clin. Cancer Res. 6:979-986(2000).
//